Dr Javad Sholehvar, MD in Emmaus, PA - Otolaryngology

Dr Javad Sholehvar, MD is a Otolaryngology physician based in Emmaus, Pennsylvania. Dr Javad Sholehvar is licensed to practice in Pennsylvania (license number MD 031405 L) and his current practice location is 708 Eagle Dr, Emmaus, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (484) 788-9674.

NPI number for Dr Javad Sholehvar is 1598099111 and his current mailing address is 708 Eagle Dr, Emmaus, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1598099111.

Contact Information

	Dr Javad Sholehvar, MD
	708 Eagle Dr, Emmaus, PA 18049-1933
	(484) 788-9674
	(484) 788-9674

Physician's Profile

Full Name	Dr Javad Sholehvar
Gender	Male
Speciality	Otolaryngology
Location	708 Eagle Dr, Emmaus, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1598099111
Provider Enumeration Date: 09/29/2009
Last Update Date: 01/15/2016

Medical Identifiers

Medical identifiers for Dr Javad Sholehvar such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1598099111	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	MD 031405 L (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Javad Sholehvar is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Javad Sholehvar, MD 708 Eagle Dr, Emmaus, PA 18049-1933 Ph: (484) 788-9674	Dr Javad Sholehvar, MD 708 Eagle Dr, Emmaus, PA 18049-1933 Ph: (484) 788-9674

News Archive

State roundup: AP probes Va. hospital's actions in woman's death; Supreme Court won't hear Neb. abortion case; Kancare preps assessment for in-home Medicaid needs

An Associated Press examination of her care highlights the dizzying array of federal, state and private agencies charged with regulating hospital care, and the differing standards they use when investigating the most serious cases of possible neglect. In addition, an investigation report filed by Virginia regulators appears to have been altered to delete parts of the report that substantiated most of the family's complaints. That prompted a former top federal regulator to say the case warrants further investigation.

Charles Sherr awarded distinction of AAAS Fellow

Charles Sherr, M.D., Ph.D., co-chair of Genetics and Tumor Cell Biology at St. Jude Children's Research Hospital and a Howard Hughes Medical Institute Investigator, has been awarded the distinction of American Association for the Advancement of Science (AAAS) Fellow. AAAS is the world's largest general scientific society.

NanoPhos, Keraben co-develop novel line of self-cleaning and sterilizing ceramic tiles

NanoPhos SA, a nanotechnology company, and the leading ceramic tile manufacturer KERABEN co-developed LIFEKER(R), an innovative line of self-cleaning and self-sterilizing ceramic tiles. These properties of LIFEKER(R) tiles are provided by the use of the SurfaShield(R) coating technology developed by NanoPhos, which is activated simply by the energy of surrounding light (either sunlight or artificial lighting) without the use of dangerous chemicals.

Study shows nonwhite physicians attain better pain control using less analgesia

Research has shown that patients from ethnic minority groups receive less analgesic-based pain treatment in emergency departments than whites, however, a study published in The Journal of Pain reports that nonwhite physicians achieve better pain control using less analgesia.

Does treating worms in people with HIV slow progression to AIDS?

Of the 25 million people infected with HIV-1 in Africa, as many as half are thought to be co-infected with worms (helminths), and there is evidence that these worms may result in a more rapid progression of HIV infection to AIDS.

Dr Javad Sholehvar, MD - Otolaryngology in Emmaus, PA